Skip to main content
logo
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.17
-0.15 (-1.61%)
At close: Jul 24, 2026, 4:00 PM EDT
9.18
+0.01 (0.11%)
After-hours: Jul 24, 2026, 7:34 PM EDT

CRBP Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.88
Revenue Growth (YoY)
------77.61%
Gross Profit
-----0.88
Selling, General & Admin
15.5715.2216.513.9118.720.43
Research & Development
74.2770.132.2231.1716.1436.45
Other Operating Expenses
----5-
Total Operating Expenses
89.8485.3148.7245.0839.8456.87
Operating Income
-89.84-85.31-48.72-45.08-39.84-55.99
Interest Income
5.255.536.311.64--
Interest Expense
---1.87-3.86--
Other Non-Operating Income (Expense)
-0.071.244.072.7-2.8922.53
Total Non-Operating Income (Expense)
5.186.778.510.47-2.8922.53
Pretax Income
-84.66-78.54-40.21-44.6-42.73-33.46
Net Income
-84.53-78.54-40.21-44.6-42.35-45.64
Net Income to Common
-84.53-78.54-40.21-44.6-42.35-45.64
Net Income Growth
------
Shares Outstanding (Basic)
3,0891311444
Shares Outstanding (Diluted)
3,0891311444
Shares Change (YoY)
2.53%22.00%152.23%3.76%1.85%57.23%
EPS (Basic)
-5.82-5.90-3.68-10.31-10.15-11.15
EPS (Diluted)
-5.82-5.90-3.68-10.31-10.15-11.15
EPS Growth
------
Free Cash Flow
-73.64-64.5-41.79-36.1-37.56-48.24
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.02-4.84-3.83-8.34-9.01-11.78
Gross Margin
-----100.00%
Operating Margin
------6350.09%
Profit Margin
------5176.38%
FCF Margin
------5470.98%
EBITDA
-89.64-85.08-48.13-44.44-39.07-54.35
EBITDA Margin
------6164.17%
EBIT
-89.84-85.31-48.72-45.08-39.84-55.99
EBIT Margin
------6350.09%
SEC Filings: 10-K · 10-Q